Decision letter for "Discovery of GBA-16-24 as a highly potent, selective ATR inhibitor for the treatment of FLT3-mutated acute myeloid leukemia"

Publons reviews and discussion 2026

View at publisher
DOI: 10.1039/d5md01005e/v1/decision1
Cited by: 0

Fields of Study & Subjects

Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Chronic Lymphocytic Leukemia Research

Publication details

Journal / source
Publons reviews and discussion
Publication date
23 January 2026
Language
EN